Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease

NCT05137756 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05137756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05137756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Completed
Start date
December 1, 2019
Completion date
October 1, 2021
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

5 day multidisciplinary evaluation in amc clinic of the national reference center, diagnosis of arthrogryposis amyoplasia or distal arthrogryposis, with physical medecin, medical genetic and imaging departments at the hospital grenoble alpes